← Back to Search

CLS-R-FUERTE for Attention Deficit Hyperactivity Disorder (ADHD)

N/A
Waitlist Available
Led By Lauren M Haack, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and post treatment (8 weeks)
Awards & highlights

Study Summary

This trial is testing a remote training program for school clinicians to see if it's more effective than usual care for treating ADHD/ODD in Mexican youth.

Eligible Conditions
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • ODD
  • Oppositional Defiant Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and post treatment (8 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and post treatment (8 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change Impairment Rating Scale (IRS) Parent Questionnaire Overall Severity Score
Change Impairment Rating Scale (IRS) Teacher Questionnaire Overall Severity Score
Change in Child Symptom Inventory-4 (CSI-4) Parent Checklist (Oppositional Defiant Disorder) ODD Symptom Severity Score
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CLS-R-FUERTEExperimental Treatment1 Intervention
Active program participation in: a remote school clinician training and comprehensive psychosocial intervention designed to improve attention and behavior in Mexican school-aged youth (grades 1-5). via school clinician training by a clinical research team to lead parent skill groups, child skill groups, and teacher consultation in a behavioral classroom management system.
Group II: Care-As-UsualActive Control1 Intervention
Continued participation in school care-as-usual
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CLS-R-FUERTE
2022
N/A
~170

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,774 Previous Clinical Trials
2,674,236 Total Patients Enrolled
94 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
19,884 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
University of California, San FranciscoLead Sponsor
2,492 Previous Clinical Trials
11,930,617 Total Patients Enrolled
7 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
689 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Lauren M Haack, PhDPrincipal InvestigatorUniversity of California, San Francisco
1 Previous Clinical Trials
69 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
69 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies available for enrolment in this experiment?

"Per the information on clinicaltrials.gov, this research project is no longer accepting participants. Initially posted on September 1st 2022 and edited most recently at the end of November that same year, it has since been discontinued; however, there are currently 144 other studies actively recruiting patients."

Answered by AI
~65 spots leftby Mar 2025